Skip to content
MedsAcross

Molecule

Azelaic acid

Decreased Protein Synthesis
Available on requestDermatology
Presentations
3
Brands
2
Manufacturers
2
Available from stock
0

Azelaic acid is a prescription medicine indicated for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea. It is available as gel, cream and foam for topical and cutaneous use. MedsAcross supplies Azelaic acid for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class
Decreased Protein Synthesis, Decreased Sebaceous Gland Activity
ATC classification
D10AX03 Azelaic acid · Acne treatments, subgroup D10A, subgroup D10AX
US FDA first approval
13 September 1995
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Topical, Cutaneous
Dosage forms
Gel, Cream, Foam
Identifiers
UNII F2VW3D43YTRxCUI 18602CAS 123-99-9DrugBank DB00548Q413504

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

Azelaic acid gel, 15% is indicated for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea. Limitations of Use Efficacy for treatment of erythema in rosacea in the absence of papules and pustules has not been evaluated. Limitations of Use Although some reduction of erythema which was present in patients with papules and pustules of rosacea occurred in clinical studies, efficacy for treatment of erythema in rosacea in the absence of papules and pustules has not been evaluated.

Source: US FDA prescribing information

How it works

The mechanism(s) by which azelaic acid interferes with the pathogenic events in rosacea are unknown.

Source: US FDA prescribing information

Dosing overview

Cleanse affected area(s) using only very mild soaps or soapless cleansing lotion and pat dry with a soft towel before application of azelaic acid gel. Apply and gently massage a thin layer of azelaic acid gel into the affected areas on the face twice daily (morning and evening). Wash hands immediately following application of azelaic acid gel. Cosmetics may be applied after the application of azelaic acid gel has dried. Reassess the diagnosis if no improvement is observed upon completing 12 weeks of therapy. Avoid the use of occlusive dressings or wrappings. Instruct patients to avoid use of alcoholic cleansers, tinctures and astringents, abrasives and peeling agents. For topical use. Not for oral, ophthalmic or intravaginal use. Apply a thin layer twice daily to affected area(s).

Source: US FDA prescribing information

Warnings and precautions

Hypersensitivity: Hypersensitivity reactions, including cases of angioedema, eye swelling, facial swelling, dyspnea, urticaria, and adverse skin reactions, have been reported. In case of known hypersensitivity to any component of the gel, avoid the use of azelaic acid gel. If hypersensitivity develops, discontinue treatment and institute appropriate therapy. Skin Reactions: Skin irritation (i.e. pruritus, burning or stinging) may occur, usually during the first few weeks of treatment. If sensitivity or severe irritation develops and persists, discontinue treatment and institute appropriate therapy. Hypopigmentation: Isolated cases of hypopigmentation occurred after azelaic acid use. Monitor patients with dark complexion for early signs of hypopigmentation. Eye and Mucous Membrane Irritation: azelaic acid gel has been reported to cause irritation of the eyes.

Source: US FDA prescribing information

Side effects

The most common adverse reactions are burning/stinging/tingling (29%), pruritus (11%), scaling/dry skin/xerosis (8%) and erythema/irritation (4%).

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

3 presentations of Azelaic acid, sorted by availability.

MedicineManufacturerRegisterAvailability
Azelaic acid 15% gelTopicalGeneric name—US FDAAvailable on request
Azelex 20% creamCutaneousAlmirallUS FDAAvailable on request
Finacea Foam 15% foamTopicalLEO PharmaUS FDAAvailable on request

Brands by market

2 brand names across 1 markets.

Brand names by country

United States

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 13 September 1995Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Conditions

Conditions linked to Azelaic acid in public data. This is not a list of approved uses, see the clinical information.

Questions and answers

Is Azelaic acid available for export from India?

Yes, on request. MedsAcross lists 3 presentations of Azelaic acid and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Azelaic acid have?

The catalogue lists 2 brand names for Azelaic acid, including Azelex, Finacea Foam.

Is Azelaic acid approved by the US FDA?

Yes. The US FDA first approved Azelaic acid on 13 September 1995, according to Drugs@FDA.

Does Azelaic acid need cold chain shipping?

No listed presentation of Azelaic acid is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

Which ATC class is Azelaic acid in?

Azelaic acid is classified under ATC code D10AX03 (Azelaic acid).

References

  1. Azelaic Acid Gel prescribing information (Sandoz). U.S. National Library of Medicine, DailyMed. Retrieved 11 November 2021

Request Azelaic acid for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.